Get started
CATHAY SECURITIES CORPORATION GLOBAL GENOMICS IMMUNOLOGY & MEDICAL REVCATHAY SECURITIES CORPORATION GLOBAL GENOMICS IMMUNOLOGY & MEDICAL REVCATHAY SECURITIES CORPORATION GLOBAL GENOMICS IMMUNOLOGY & MEDICAL REV

CATHAY SECURITIES CORPORATION GLOBAL GENOMICS IMMUNOLOGY & MEDICAL REV

No trades
See on Supercharts
Overview
Analysis News Ideas Technicals

00898 chart

Key stats

Assets under management (AUM)
‪1.93 B‬TWD
Fund flows (1Y)
‪−524.03 M‬TWD
Dividend yield (indicated)
—
Discount/Premium to NAV
−0.4%

About CATHAY SECURITIES CORPORATION GLOBAL GENOMICS IMMUNOLOGY & MEDICAL REV

Issuer
Cathay Financial Holdings Co., Ltd.
Brand
Cathay
Expense ratio
1.05%
Home page
cathaysite.com.tw
Inception date
Nov 22, 2021
Index tracked
Solactive Global Genomics Immunology and Medical Revolution Index - Benchmark TR Net
Management style
Passive
ISIN
TW0000089804
1 90%() 2 1 () 100%

Classification

Asset Class
Equity
Category
Sector
Focus
Health care
Niche
Health care equipment & services
Strategy
Vanilla
Weighting scheme
Market cap
Selection criteria
Market cap

Analysis

What's in the fund
Exposure type
StocksBonds, Cash & Other
Health Technology
Stock breakdown by region
84%12%3%

News

Keep reading

Technicals

Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy